Lapatinib
Active substance: lapatinib ditosylate
TABLET · LAPATINIB DITOSYLATE 250 mg/1
United StatesActive
Marketing holder: Lupin Pharmaceuticals, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- LAPATINIB DITOSYLATE · 250 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208f-8a4b-7650-a4fc-42a29e3eecaf,01a12095-ba5c-797e-b339-e6c0b80dd0ee,01a1209e-14cc-7d2b-83fa-382bb617a6f0,01a1209e-5b87-7100-ad3d-03716068d33d;count=4 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 68180-801
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 68180-801 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 68180-801 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 68180-801 · Verified 2026-10-09 · open in source